ERBB2 and lung cancer: We have now shown that several RTKs, including EGFR, human EGFR (HER)2, HER3, and RET in addition to MET, are highly phosphorylated in MET amplification-positive lung cancer cells, and that these RTKs form heterodimers with MET.